ADLAI NORTYE LTD. Share Price Today: Live Updates & Key Insights
ADLAI NORTYE LTD. share price today is $7.5, up 0.54%. The stock opened at $7.27 against the previous close of $7.36, with an intraday high of $7.67 and low of $6.73.
ADLAI NORTYE LTD. Share Price Chart
ADLAI NORTYE LTD.
ADLAI NORTYE LTD. Share Price Performance
ADLAI NORTYE LTD. Institutional Holdings
ADLAI NORTYE LTD. Market Status
ADLAI NORTYE LTD. Fundamentals
Market Cap 434.68 M
PB Ratio 54.5803
PE Ratio 0.0
Enterprise Value 432.75 M
Total Assets 71.27 M
Volume 251921
ADLAI NORTYE LTD. Company Financials
About ADLAI NORTYE LTD. & investment objective
Company Information Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and development of pharmaceutical products. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trials to induce and stabilize PD-L1 dimerization and disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.
Organisation Biotechnology
Employees 123
Industry Biotechnology
CEO Mr. Yang Lu
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ADLAI NORTYE LTD. FAQs
What is the share price of ADLAI NORTYE LTD. today?
The current share price of ADLAI NORTYE LTD. is $7.5.
Can I buy ADLAI NORTYE LTD. shares in India?
Yes, Indian investors can buy ADLAI NORTYE LTD. shares by opening an international trading and demat account with Motilal Oswal.
How to buy ADLAI NORTYE LTD. shares in India?
You can easily invest in ADLAI NORTYE LTD. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ADLAI NORTYE LTD. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ADLAI NORTYE LTD..
Can I buy fractional shares of ADLAI NORTYE LTD.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ADLAI NORTYE LTD.?
ADLAI NORTYE LTD. has a market cap of $434.68 M.
In which sector does ADLAI NORTYE LTD. belong?
ADLAI NORTYE LTD. operates in the Biotechnology sector.
What documents are required to invest in ADLAI NORTYE LTD. stocks?
To invest, you typically need:
What is the PE and PB ratio of ADLAI NORTYE LTD.?
The PE ratio of ADLAI NORTYE LTD. is N/A and the PB ratio is 54.58.